Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 7, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Variation of SARS-CoV-2 genomes in populations due to RNA editing enzymes

NICED Life Science Non-Medical Scientist Recruitment | Rs. 48,000 pm Pay

Linked read sequencing reveals the ecological resilience of a human gut microbial community during antibiotic treatment

Variation of SARS-CoV-2 genomes in populations due to RNA editing enzymes
  • BiotechToday
  • India

Variation of SARS-CoV-2 genomes in populations due to RNA editing enzymes

bioxone December 14, 2020December 14, 2020

Prama Ghosh, Amity University Kolkata

The SARS-CoV-2 virus has infected millions around the globe since its transmission in the human host. Extensive diversification of the virus including significant molecular differences has resulted in failure to diagnose the virus. The virus undergoes continuous evolution and adaptation inside the body of the host, which helps it to survive in the host’s body.

Recently, RNA editing by APOBEC and ADAR family of enzymes has been implicated as the most significant driver of intra-host variability of the SARS-CoV-2 genomes. Insights on the consequence of RNA editing on the establishment, spread and functional outcomes of the virus can be provided by analysis of the intrahost single-nucleotide variations (iSNVs) in SARS-CoV-2 genomes at spatio-temporal scales. 

On conducting a study using 1,347 transcriptomes of COVID-19 infected patients across various populations, variable prevalence of iSNVs was observed with distinctly higher levels in Indian population. The results also suggest that iSNVs can establish variants in a population. Key structural and functional changes in the Spike protein that confer antibody resistance is also contributed by these iSNVs.

Thus, iSNVs in the SARS-CoV-2 genomes could be used as surrogates for ongoing host-mediated RNA editing activity, highlighting the need to capture iSNVs for empowering more precise models for molecular epidemiology as well as for diagnostics and vaccine design.

Also read: Usherin – The critical proteins for sensing vibrations

Reference: Intra-host variability in global SARS-CoV-2 genomes as signatures of RNA editing: implications in viral and host response outcomes

Ankit K. Pathak, Saman Fatihi, Tahseen Abbas, Bharathram Uppili, Gyan Prakash Mishra, Arup Ghosh, Sofia Banu, Rahul C. Bhoyar, Abhinav Jain, Mohit Kumar Divakar, Mohamed Imran, Mohammed Faruq, Divya Tej Sowpati, Sunil K. Raghav, Lipi Thukral, Mitali Mukerji

 doi: https://doi.org/10.1101/2020.12.09.417519

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged ADAR antiviral response APOBEC genomics host response Hyper-editing iSNVs RNA Editing SARS-CoV-2 SNVs spike protein

2 thoughts on “Variation of SARS-CoV-2 genomes in populations due to RNA editing enzymes”

  1. Pingback: Linked read sequencing reveals the ecological resilience of a human gut microbial community during antibiotic treatment - BioXone
  2. Pingback: Genome editing by CRISPR-CAS9 to treat ATRT - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Linked read sequencing reveals the ecological resilience of a human gut microbial community during antibiotic treatment

bioxone December 14, 2020

Souradip Mallick, National Institute of Technology, Rourkela The gastrointestinal metagenome is aggregation of all the genomes of gut microbiota. The gut flora is established after birth, by which time the intestinal epithelium and the intestinal mucosal barrier that it secretes developed its tolerance and also provides a barrier to pathogenic organisms. The relationship between gut flora and humans is not merely commensal but rather a mutualistic  relationship. […]

read sequencing

Related Post

  • BiotechToday
  • World

The device helps individuals with paralysis in communication

bioxone July 18, 2021July 18, 2021

Shrestha Dutta, Amity University Kolkata Scientists have developed brain waves of a paralyzed man who is unable to speak to form words from his contemplations onto a computer.  A group of scientists carried out research and the results of the same were published on 15th July in the New England Journal of Medicine. According to […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Clinical Chemistry Analyzer in Laboratory Setting

bioxone November 24, 2020November 24, 2020

Sagnik Nag, Amity University Kolkata On November 18, 2020, the Medica EasyRA benchtop clinical chemistry analyzer was distributed and serviced by Greensboro-based company, which provides healthcare officials and staff to keep a routine test on blood chemistries to include and check metabolic activity profiles, liver enzymes, proper kidney functioning glucose levels, and cardiovascular tests. These […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Antacid medication to help control diabetes

BioTech Today June 29, 2021June 28, 2021

Soumya Shraddhya Paul, Amity University Noida Diabetes has been a great area of concern for many people especially due to changing lifestyles as well as due to genetic reasons. Type 2 diabetes as of now affects 10% of the population worldwide and currently, the treatments which are prescribed by doctors involve lifestyle changes, insulin shot […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy